Search
Co-Diagnostics Inc
CODXAdd to Watchlist
0.353USD
-0.014-3.81%
Close 11-02 16:00（ET）
3.11MMarket Cap
0.00P/E TTM
Co-Diagnostics Inc (CODX) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Co-Diagnostics Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
4.000USD+69.49%
CODX Analyst Recommendation Trends
In the current month, CODX has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CODX average Analyst price target in the last month is 4.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
1
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
2
2
2
2
CODX Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
8
1
0
34
Boston Scientific Corp
BSX
7
14
11
1
0
33
Edwards Lifesciences Corp
EW
10
15
6
0
0
31
Thermo Fisher Scientific Inc
TMO
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Waters Corp
WAT
8
10
6
0
0
24
Resmed Inc
RMD
3
8
10
1
1
23
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Financial Forecasting
Based on analysts' estimates, CODX EPS is projected to reach -1.250 in FY2026Q3, following reported EPS of -1.458 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.60
-3.75
-3.00
-1.25
-0.27
Actual
-13.67
-4.06
-1.46
--
--
Surprise
-279.65%
-8.16%
+51.40%
--
--
FAQs
What is Co-Diagnostics Inc's expected revenue for the next quarter?
Co-Diagnostics Inc's expected revenue is 169.00K.
What is Co-Diagnostics Inc's price target?
Analysts forecast that Co-Diagnostics Inc's price target is USD 4.00, with the highest forecast at USD 4.00 and the lowest forecast at USD 4.00.
How have Co-Diagnostics IncCODX's recent earnings per share performed?
The market expectation was USD -1.46, while Co-Diagnostics IncCODX's earnings per share (EPS) for the previous quarter was USD -4.06. EPS for the next quarter is expected at USD -1.25.
What is the analyst rating for Co-Diagnostics Inc?
Based on the ratings of Co-Diagnostics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.